4791 related articles for article (PubMed ID: 3743866)
1. Quantitative evaluation of anticancer agents against human melanoma cells implanted in nude mice.
Lockshin A; Giovanella BC; Stehlin JS
Exp Cell Biol; 1986; 54(3):149-54. PubMed ID: 3743866
[TBL] [Abstract][Full Text] [Related]
2. Exceptional lethality for nude mice of cells derived from a primary human melanoma.
Lockshin A; Giovanella BC; De Ipolyi PD; Williams LJ; Mendoza JT; Yim SO; Stehlin JS
Cancer Res; 1985 Jan; 45(1):345-50. PubMed ID: 3965144
[TBL] [Abstract][Full Text] [Related]
3. Effectiveness of anticancer drugs determined in nude mice inoculated with [125I]5-iodo-2'-deoxyuridine-prelabeled human melanoma cells.
Lockshin A; Giovanella BC; Vardeman DM; Mendoza JT; Quian C; Kozielski T; Stehlin JS
J Natl Cancer Inst; 1985 Apr; 74(4):899-903. PubMed ID: 3921748
[TBL] [Abstract][Full Text] [Related]
4. Hyaluronidase pretreatment produces selective melphalan enrichment in malignant melanoma implanted in nude mice.
Muckenschnabel I; Bernhardt G; Spruss T; Buschauer A
Cancer Chemother Pharmacol; 1996; 38(1):88-94. PubMed ID: 8603457
[TBL] [Abstract][Full Text] [Related]
5. The influence of P170-glycoprotein modulators on the efficacy and the distribution of vincristine as well as on MDR1 expression in BRO/mdr1.1 human melanoma xenografts.
Boven E; Jansen WJ; Hulscher TM; Beijnen JH; van Tellingen O
Eur J Cancer; 1999 May; 35(5):840-9. PubMed ID: 10505047
[TBL] [Abstract][Full Text] [Related]
6. Lack of antitumour activity of human recombinant tumour necrosis factor-alpha, alone or in combination with melphalan in a nude mouse human melanoma xenograft system.
Furrer M; Altermatt HJ; Ris HB; Althaus U; Rüegg C; Liénard D; Lejeune FJ
Melanoma Res; 1997 Aug; 7 Suppl 2():S43-9. PubMed ID: 9578416
[TBL] [Abstract][Full Text] [Related]
7. Prediction of anticancer activity by tumor uptake of radiolabeled monoclonal antibody.
Lockshin A; Kozielski T; Stehlin JS
Cancer Lett; 1986 Jan; 30(1):1-9. PubMed ID: 3943076
[TBL] [Abstract][Full Text] [Related]
8. Misonidazole enhancement of the action of BCNU and melphalan against human melanoma xenografts.
Clutterbuck RD; Millar JL; McElwain TJ
Am J Clin Oncol; 1982 Feb; 5(1):73-8. PubMed ID: 7081141
[TBL] [Abstract][Full Text] [Related]
9. Establishment of a melphalan-resistant rhabdomyosarcoma xenograft with cross-resistance to vincristine and enhanced sensitivity following buthionine sulfoximine-mediated glutathione depletion.
Rosenberg MC; Colvin OM; Griffith OW; Bigner SH; Elion GB; Horton JK; Lilley E; Bigner DD; Friedman HS
Cancer Res; 1989 Dec; 49(24 Pt 1):6917-22. PubMed ID: 2582434
[TBL] [Abstract][Full Text] [Related]
10. Correlation between response to chemotherapy of human tumors in patients and in nude mice.
Giovanella BC; Stehlin JS; Shepard RC; Williams LJ
Cancer; 1983 Oct; 52(7):1146-52. PubMed ID: 6883283
[TBL] [Abstract][Full Text] [Related]
11. Antitumor effect of human fibroblast interferon on the growth of human melanoma cells implanted in nude mice.
Ida N; Uenishi N; Kajita A; Satoh Y
Gan; 1982 Dec; 73(6):952-60. PubMed ID: 7160584
[TBL] [Abstract][Full Text] [Related]
12. A nude rat model for neutron capture therapy of human intracerebral melanoma.
Barth RF; Matalka KZ; Bailey MQ; Staubus AE; Soloway AH; Moeschberger ML; Coderre JA; Rofstad EK
Int J Radiat Oncol Biol Phys; 1994 Mar; 28(5):1079-88. PubMed ID: 8175392
[TBL] [Abstract][Full Text] [Related]
13. Effect of five antineoplastic agents on tumor xenografts with different growth rates.
Mattern J; Wayss K; Volm M
J Natl Cancer Inst; 1984 Jun; 72(6):1335-9. PubMed ID: 6587154
[TBL] [Abstract][Full Text] [Related]
14. In vitro and in vivo enhancement of vincristine antitumor activity on B16 melanoma cells by calcium antagonist flunarizine.
Bellelli A; Camboni C; de Luca G; Materazzi M; Mattioni M; Sezzi ML; Bellelli L
Oncology; 1987; 44(1):17-23. PubMed ID: 3561923
[TBL] [Abstract][Full Text] [Related]
15. Correlation of cytotoxicity with elimination of iodine-125 from nude mice inoculated with prelabeled human melanoma cells.
Lockshin A; Giovanella BC; Quian C; Mendoza JT; Vardeman DM; Stehlin JS
J Natl Cancer Inst; 1984 Aug; 73(2):417-22. PubMed ID: 6589433
[TBL] [Abstract][Full Text] [Related]
16. Reciprocal cross-resistance in human rhabdomyosarcomas selected in vivo for primary resistance to vincristine and L-phenylalanine mustard.
Horton JK; Houghton PJ; Houghton JA
Cancer Res; 1987 Dec; 47(23):6288-93. PubMed ID: 2890432
[TBL] [Abstract][Full Text] [Related]
17. STI571 combined with vincristine greatly suppressed the tumor formation of multidrug-resistant K562 cells in a human-nude mice xenograft model.
Gao L; Chen L; Fei XH; Qiu HY; Zhou H; Wang JM
Chin Med J (Engl); 2006 Jun; 119(11):911-8. PubMed ID: 16780770
[TBL] [Abstract][Full Text] [Related]
18. Use of nude mouse xenografts as preclinical drug screens: in vivo activity of established chemotherapeutic agents against melanoma and ovarian carcinoma xenografts.
Taetle R; Rosen F; Abramson I; Venditti J; Howell S
Cancer Treat Rep; 1987 Mar; 71(3):297-304. PubMed ID: 3815395
[TBL] [Abstract][Full Text] [Related]
19. Comparison of the Lonidamine Potentiated Effect of Nitrogen Mustard Alkylating Agents on the Systemic Treatment of DB-1 Human Melanoma Xenografts in Mice.
Nath K; Nelson DS; Putt ME; Leeper DB; Garman B; Nathanson KL; Glickson JD
PLoS One; 2016; 11(6):e0157125. PubMed ID: 27285585
[TBL] [Abstract][Full Text] [Related]
20. A model of human cancer metastasis: extensive spontaneous and artificial metastasis of a human pigmented melanoma and derived variant sublines in nude mice.
Kerbel RS; Man MS; Dexter D
J Natl Cancer Inst; 1984 Jan; 72(1):93-108. PubMed ID: 6582307
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
